Technical Description
The present invention relates to synthesis of novel sulfonamide derivatives of para-amino benzoic acid as selective butrylcholinesterase (BuChE) inhibitors for the treatment of Alzheimer’s disease.
Problems Addressed
- Neurodegeneration
- Acetylcholine Depletion
- Ineffective Existing Treatments
- Undesirable Side Effects
Tech Features
- Novel Compound
- Selective BuChE Inhibitor
- Low Ic50 Value
- Prevention and Delayed Alzheimer
- Targeted Treatment
- Minimal Side Effects
Target Audience
- Medical and Healthcare Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research & Development
Tech ID: P35-1350 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
